Genzyme CEO: Sanofi proxy battle unlikely; Teva, APP Pharma partner on copycat Gemzar;

 @FiercePharma: Sanofi, BMS win 6 more months for Plavix. Report | Follow @FiercePharma

> A proxy battle for control of Genzyme is unlikely, given the progress being made in discussions with Sanofi-Aventis, CEO Henri Termeer said at the economic summit in Davos. Item | Report

> Teva Pharmaceutical Industries and a unit of Fresenius Kabi agreed to manufacture and market a generic version of Eli Lilly's chemo drug Gemzar, allowing Teva to take advantage of its 180-day exclusivity period. Story

> GlaxoSmithKline lost a Dutch patent case on its top-selling lung drug Advair, in the latest in a series of legal battles across Europe over the inhaled medicine. Item

> Lundbeck, the sole U.S. manufacturer of a sedative that Ohio plans to use to execute death row inmates--and that Oklahoma already uses to do so--said it opposes the practice and has asked both states to stop using the drug. News

> The U.K.'s cost-effectiveness watchdog has changed its mind about Bristol-Myers Squibb's and Otsuka Pharmaceuticals Abilify, deciding to recommend the drug as a schizophrenia treatment for young people. Article

> Amylin Pharmaceuticals reported a narrower net loss for the fourth quarter as lower costs--including the elimination of employee bonuses--helped offset weaker sales of Byetta, a diabetes drug it sells with Eli Lilly. News

Biotech News

 @FierceBiotech:   Abbott chops 1,900 workers after experimental drugs flop. News | Follow @FierceBiotech

 @JohnCFierce: Promosome raises $4.1M in venture cash. working on "enhanced protein expression in...relevant bioproduction platforms." Story |  Follow @JohnCFierce

> Investigators discover a new approach to Alzheimer's. Article 

> CA stem cell agency counts rewards from $1.1B bonanza. News

> Philanthropist sets up new venture fund for CF. Report

> Ligand snaps up CyDex in $35.5M buyout. Story 

Vaccines News

> Report: Cholera vax helpful after outbreak. News

> Gates: Disease prevention most beneficial in developing countries. Story

> Northwest Biotherapeutics restarts DCVax trial enrollment. Item

> Merck plans copy of Rotateq in India. Article

> Generex unit expands AE37 study. Report

Manufacturing News

> Genzyme pays back $6M jobs incentive. News

> DHL gets CMO, Envirotainer nods. Item 

> Abbott jobs axe hits manufacturing. Article 

> Suspecting abuse-resistant Oxycontin, buyer kills dealer. Story 

> Mitsubishi Tanabe's 2M-unit recall follows QC lapse. Item 

> Ohio names replacement drug for executions. Report

And Finally... Allergan and Johnson & Johnson breast implants were linked in a U.S. review to a rare type of cancer, challenging again the safety of the decades-old products. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.